Self-diluting Microfluidic Device for Rapid Antimicrobial Susceptibility Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antimicrobial susceptibility testing methods, such as broth microdilution and disc diffusion, are time-consuming, require laboratory conditions, and are not user-friendly for non-specialists, leading to inefficiencies and resource wastage.

Innovation Solution

A self-diluting microfluidic device (SDFAST) that uses integrated dielectrophoresis and SlipChip technology with preloaded multiplex array PCR, featuring nanolitre-sized wells for self-generation of dilution gradients, allowing for rapid antimicrobial susceptibility testing without the need for pumps or valves.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If broth microdilution method is used, then precise MIC determination is achieved, but testing duration extends to 72 hours and requires laboratory conditions

Engineering Contradiction:
ImproveMIC determination accuracyVSAvoidtesting duration
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces manual mechanical operations (pipetting, mixing, incubation monitoring) with an automated microfluidic system that performs serial dilutions and bacterial growth assessment automatically. The microfluidic device uses integrated pumps and channels to deliver precise volumes and mix reagents, eliminating manual intervention while maintaining measurement precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The testing process is segmented into distinct microfluidic modules: a dilution module for serial antibiotic dilutions, an incubation module for bacterial growth, and a detection module for turbidity measurement. This segmentation allows parallel processing of multiple samples and concentrations, reducing total testing time while preserving accuracy.

Inventive Principle:
Principle #1Segmentation

2Ease of operation

If disc diffusion method is used, then qualitative susceptibility determination is achieved, but antibiotic MIC values and quantitative data are not obtained

Engineering Contradiction:
Improvemethod simplicityVSAvoidquantitative MIC data
Core Design Contradiction:
Ease of operationVSLoss of information

Solution Approach 1:

The microfluidic device performs multiple functions within a single platform: it conducts serial dilutions like broth microdilution, provides qualitative results like disc diffusion, and additionally delivers quantitative MIC values through automated optical detection. This multi-functionality eliminates the need to choose between simplicity and data richness.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The device uses optical detection of color/turbidity changes in the microfluidic wells to determine bacterial growth inhibition. This colorimetric approach provides both the visual simplicity of disc diffusion interpretation and the quantitative precision of spectrophotometric measurement, yielding exact MIC values.

Inventive Principle:
Principle #32Color changes

3Extent of automation

If conventional microfluidic devices are used, then automation capabilities are provided, but device complexity and difficulty of operation increase for non-specialists

Engineering Contradiction:
Improvetesting automationVSAvoiduser-friendliness
Core Design Contradiction:
Extent of automationVSEase of operation

Solution Approach 1:

The microfluidic device is designed with self-aligning features and pre-loaded reagent reservoirs that automatically configure the testing protocol. The system performs self-diagnosis and error correction, and provides step-by-step guidance through software interfaces, allowing non-specialists to operate it without extensive training while maintaining high automation.

Inventive Principle:
Principle #25Self-service

4Adaptability or versatility

If broth microdilution method is used, then comprehensive antibiotic testing is achieved, but resource consumption and time investment increase significantly

Engineering Contradiction:
Improvetesting comprehensivenessVSAvoidtesting efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent transitions from traditional two-dimensional microwell plates to a three-dimensional microfluidic architecture with vertical channel stacks and layered structures. This enables parallel processing of multiple antibiotic concentrations and bacterial strains simultaneously, increasing throughput and efficiency while maintaining comprehensive testing capabilities.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

SDFAST enables quick and accurate antimicrobial susceptibility testing, reducing dilution time to seconds and processing time to 4-6 hours, making it a user-friendly point-of-care diagnostic tool that conserves resources and provides results promptly.

Implementation Method 1

The self-diluting microfluidic device combines integrated dielectrophoresis (DEP), SlipChip technology, and preloaded multiplex array PCR

Methodology Applied
Scientific EffectDielectrophoresis: Dielectric

Implementation Method 2

The bottom microchip incorporates complementary designs mirroring the wells of the top microchip, thereby creating fluidic channels connecting the ducts

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentUS20250101487A1Self-diluting microfluidic device for rapid antimicrobial susceptibility tests
Publication Date: 2025.03.27 ADVANCED BIOMEDICAL INSTRUMENTATION CENTRE LIMITED
  • US20250101487A1 patent drawing
  • US20250101487A1 patent drawing
  • US20250101487A1 patent drawing

AI summary

The present invention relates to a SDFAST (Self Dilution for Faster Antimicrobial Susceptibility Testing), which is a microfluidic device that can perform self-dilution and does not require any pumps or valves to accomplish multiplexed microfluidic processes. SDFAST is designed using AutoCAD and fabricated using micro-milling machine. It consists of two polymethyl methacrylate (PMMA) rectangular plates which are in contact throughout the operation. The first plate is the bottom one that serves as lines of wells. The second plate is the top one that acts as a lid and seals the system. The second plate has complementary designs that echo the wells in the first plate, which allows fluidic channels to be formed.